Bindlysh Biotec Limited - Due diligence report

A 360° intelligence report on Bindlysh Biotec Limited: trust score, financial health, credit view, compliance, directors, growth and distres…

1997-09-11 Delhi, Delhi Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bindlysh Biotec Limited — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Bindlysh Biotec Limited is assessed as Low Risk with a Trust Score of 75/100. Bindlysh Biotec Limited is an active public limited indian non-government company incorporated in 1997, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 16 Oct 2026 from the latest processed filings. Bindlysh Biotec Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
58/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Elevated gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 2 open (40.83 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Canara Bank1 48.0 cr
Compliance Score: 58/100 Moderate
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2024 - filings overdue.
  • Litigation present in 1 court forum(s).
  • 1 auditor resignation(s) filed - latest: RC CHADDA AND CO. LLP on 2020-12-28.
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
PRERAK GUPTA 01234567 Director 01/04/2018 6 yrs Approved
VIJESH GUPTA 01234567 Director 01/04/2018 6 yrs Approved
RAGINI VIJESH GUPTA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 4 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 70
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Operating for 29+ years.
Active GST registration(s).
Distress signals & risk flags
Profit declined two years in a row.
Statutory filings appear overdue.
Compliance score is weak (58/100).
2 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence67/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment55/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 40.83 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view77/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
25 Sep 2022
Director ceased
SHALINI JAIN
12 Jan 2022
Charge created
Hdfc Bank Limited - 20.83 Lakh
31 Mar 2020
Share transfer (FY 2020)
1000.00000000 shares to VIJESH GUPTA
Share transfer (FY 2020)
2000.00000000 shares to VIJESH GUPTA
29 Sep 2017
Director ceased
PRERAK GUPTA
03 Jul 2017
Director appointed
PRERAK GUPTA (Director)
03 Nov 2001
Charge created
Canara Bank - 20.00 Lakh
11 Sep 1997
Incorporated
Registered with Roc Delhi
Director appointed
VIJESH GUPTA (Director)
Director appointed
RAGINI VIJESH GUPTA (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a majority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Eatu Media Private Limited U74999DL2022PTC396957 Delhi
Omnicorp Environs & Infratech Co. Private Limited U41000DL2013PTC251838 Delhi
Ivnat Innovative Solutions Private Limited U73100DL2013PTC260313 East Delhi, Delhi
Aahmish Health Foundation U86201DL2024NPL432689 Delhi
Anugrah Sugars Private Limited U51909DL2010PTC198568 Delhi
Speed Trip Services India Private Limited U63030DL2020PTC362340 East Delhi, Delhi
Kaira International Concepts Private Limited U74140DL2014PTC274439 East Delhi, Delhi
Damont Developers Private Limited U45400DL2015PTC277365 Delhi
Hariom Holdfin Private Limited U67120DL1996PTC076207 Delhi
Texco Exim Private Limited U51505DL2002PTC114533 Delhi
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bindlysh Biotec Limited before audits and certifications: compliance score 58/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bindlysh Biotec Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Bindlysh Biotec Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Bindlysh Biotec Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Bindlysh Biotec Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bindlysh Biotec Limited an active company?

Bindlysh Biotec Limited has MCA status “Active” with a compliance score of 58/100 (Moderate).

Is Bindlysh Biotec Limited financially healthy?

Bindlysh Biotec Limited has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Bindlysh Biotec Limited?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bindlysh Biotec Limited?

Promoters hold a majority stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Bindlysh Biotec Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Bindlysh Biotec Limited up to date with its ROC filings?

Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 58/100 (Moderate).

Is it risky to lend to Bindlysh Biotec Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.